Suchergebnisse - "Gillies, Hunter"

PubPharm (47)

1

IMPAHCT : A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension

enthalten in: Pulmonary circulation | 2024

von Gillies, H. | Chakinala, M. | Dake, B. | +10

2

IMPAHCT : A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension

enthalten in: Pulmonary Circulation | 2024

von Gillies, H. | Chakinala, M. | Dake, B. | +10

3

AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants : a phase 1 single and multiple ascending dose study

enthalten in: ERJ open research | 2023

von Gillies, H. | Niven, R. | Dake, B. | +7

4

Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Results in Sustained Symptom Improvement in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

enthalten in: Frontiers in systems neuroscience | 2021

von Pereira, G. | Gillies, H. | Chanda, S. | +4

5

A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis

enthalten in: Chest | 2020

von Nathan, S. | Flaherty, K. | Glassberg, M. | +10

6

COMPOSITIONS AND METHODS OF TREATING PULMONARY HYPERTENSION

enthalten in: Europäisches Patentamt | 2018

von BELARDINELLI LUIZ | GILLIES HUNTER CAMPBELL | LIANG FAQUAN | +2

7

Composiciones y métodos de tratamiento de hipertensión pulmonar

enthalten in: Europäisches Patentamt | 2017

von BELARDINELLI LUIZ | GILLIES HUNTER | LIANG FAQUAN | +2

8

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) : subgroup analysis from the AMBITION trial

enthalten in: Annals of the rheumatic diseases | 2017

von Coghlan, J. | Galiè, N. | Barberà, J. | +15

9

Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report

enthalten in: American journal of respiratory and critical care medicine | 2017

von Newman, J. | Rich, S. | Abman, S. | +44

CommentIn: Am J Respir Crit Care Med. 2017 Jun 15;195(12 ):1558-1560. - PMID 28617089

10

Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1)

enthalten in: Respiratory medicine | 2017

von Shapiro, S. | Torres, F. | Feldman, J. | +6

1
2
3
4
5
Nächster »
[5]